Evans Thomas George 4
4 · Vaccitech plc · Filed Mar 29, 2023
Insider Transaction Report
Form 4
Vaccitech plcVACC
Evans Thomas George
Chief Scientific Officer
Transactions
- Award
Share Option (Right to Buy)
2023-01-03+125,000→ 125,000 totalExercise: $2.40Exp: 2033-01-03→ Ordinary Shares (125,000 underlying)
Footnotes (2)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 3, 2024.